Format

Send to

Choose Destination
See comment in PubMed Commons below
World J Gastroenterol. 2012 Jun 7;18(21):2727-9. doi: 10.3748/wjg.v18.i21.2727.

A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release.

Author information

1
Department of Pediatrics, Pediatric Gastroenterology and Liver Unit, Sapienza University of Rome, 00161 Rome, Italy.

Abstract

Pediatric Menetrier's disease (MD) is an uncommon, acute, self-limited hypertrophic gastropathy characterized by enlarged gastric folds associated with epithelial hyperplasia and usually accompanied by protein losing gastropathy. Gastric cytomegalovirus infection is found in one third of MD children and its treatment is often associated with remission. Diagnosis often requires full-thickness biopsy due to inability to detect typical histological findings with conventional endoscopic biopsy. We report an uncommon case of non self-limited pediatric MD needing endoscopic mucosal resection for diagnosis which was then successfully treated with octreotide long-acting release (LAR). To the best of our knowledge, this is the first pediatric MD case successfully treated with octreotide LAR. Our experience suggests octreotide LAR as treatment for refractory MD before gastrectomy.

KEYWORDS:

Children; Endoscopic mucosal resection; Menetrier’s disease; Octreotide

PMID:
22690084
PMCID:
PMC3370012
DOI:
10.3748/wjg.v18.i21.2727
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
    Loading ...
    Support Center